{"id":"https://openalex.org/W2281900984","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.3018","title":"Phase II experience with MDX-1106 (Ono-4538), an anti-PD-1 monoclonal antibody, in patients with selected refractory or relapsed malignancies","display_name":"Phase II experience with MDX-1106 (Ono-4538), an anti-PD-1 monoclonal antibody, in patients with selected refractory or relapsed malignancies","publication_year":2009,"publication_date":"2009-05-20","ids":{"openalex":"https://openalex.org/W2281900984","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.3018","mag":"2281900984"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2009.27.15_suppl.3018","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.3018","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.3018","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018401879","display_name":"Julie Renee Brahmer","orcid":"https://orcid.org/0000-0002-2443-8395","observed_orcids":["https://orcid.org/0000-0002-2443-8395"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. R. Brahmer","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052980036","display_name":"Suzanne Louise Topalian","orcid":"https://orcid.org/0000-0002-0821-8587","observed_orcids":["https://orcid.org/0000-0002-0821-8587"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. L. Topalian","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090977453","display_name":"John D. Powderly","orcid":"https://orcid.org/0000-0002-7608-0380","observed_orcids":["https://orcid.org/0000-0002-7608-0380"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Powderly","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054686559","display_name":"IRA S. WOLLNER","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I. Wollner","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034354367","display_name":"Joel Picus","orcid":"https://orcid.org/0000-0002-4038-936X","observed_orcids":["https://orcid.org/0000-0002-4038-936X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Picus","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031310463","display_name":"Charles G. Drake","orcid":"https://orcid.org/0000-0001-9610-3677","observed_orcids":["https://orcid.org/0000-0001-9610-3677"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. G. Drake","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091886021","display_name":"Elizabeth Stankevich","orcid":"https://orcid.org/0000-0002-9552-272X","observed_orcids":["https://orcid.org/0000-0002-9552-272X"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Stankevich","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036054479","display_name":"Alan J. Korman","orcid":"https://orcid.org/0000-0002-1142-8542","observed_orcids":["https://orcid.org/0000-0002-1142-8542"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Korman","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066707073","display_name":"Drew M. Pardoll","orcid":"https://orcid.org/0000-0001-6215-1013","observed_orcids":["https://orcid.org/0000-0001-6215-1013"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Pardoll","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042595034","display_name":"Isreal Lowy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]},{"id":"https://openalex.org/I4210093858","display_name":"Carolina BioOncology Institute","ror":"https://ror.org/00htvrc11","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210093858"]},{"id":"https://openalex.org/I4210164401","display_name":"Sidney Kimmel Comprehensive Cancer Center","ror":"https://ror.org/05m5b8x20","country_code":"US","type":"facility","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210164401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I. Lowy","raw_affiliation_strings":["SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SKCCC at Johns Hopkins, Baltimore, MD; Carolina BioOncology Institute, Huntersville, NC; Henry Ford Hospital, Detroit, MI; Washington University Siteman Cancer Center, St. Louis, MO; Medarex, Inc., Bloomsbury, NJ","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2803043754","https://openalex.org/I4210093858","https://openalex.org/I4210164401"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"27","issue":"15_suppl","first_page":"3018","last_page":"3018"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-pd-1-monoclonal-antibody","display_name":"anti-PD-1 monoclonal antibody","score":0.9589999914169312},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.7490000128746033},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.7329999804496765},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.6449999809265137},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.925000011920929},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.7139999866485596},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8920000195503235},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.7710000276565552},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7590000033378601},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5559999942779541},{"id":"https://openalex.org/keywords/cd8-t-cell-infiltration","display_name":"CD8+ T cell infiltration","score":0.7440000176429749}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9435802698135376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5165414214134216},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.5131586194038391},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4455128312110901},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.44296687841415405},{"id":"https://openalex.org/C2777910003","wikidata":"https://www.wikidata.org/wiki/Q1707292","display_name":"Asymptomatic","level":2,"score":0.43921852111816406},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.42818623781204224},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.415498822927475},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34821364283561707},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.3006753921508789},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18629390001296997}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2009.27.15_suppl.3018","doi":"https://doi.org/10.1200/jco.2009.27.15_suppl.3018","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2009.27.15_suppl.3018","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8899999856948853}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2049776456","https://openalex.org/W2955654676","https://openalex.org/W2592092676","https://openalex.org/W2045413621","https://openalex.org/W2378015446","https://openalex.org/W2947335179","https://openalex.org/W2151906733","https://openalex.org/W1973662639","https://openalex.org/W2262509800","https://openalex.org/W2009096079"],"abstract_inverted_index":{"3018":[0],"Background:":[1],"Programmed":[2],"death-1":[3],"(PD-1),":[4],"an":[5],"inhibitory":[6],"receptor":[7],"expressed":[8],"on":[9,259,278],"activated":[10],"T":[11,227,279],"cells,":[12],"may":[13],"suppress":[14],"antitumor":[15,326],"immunity.":[16],"This":[17],"expansion":[18],"cohort":[19],"in":[20,193,263,300],"a":[21,27,89,178,214,221,287],"phase":[22],"I/II":[23],"trial":[24],"of":[25,42,51,85,92,204,213,237,256,274,291,305],"MDX-1106,":[26],"fully":[28],"human":[29],"IgG4":[30],"antibody":[31],"blocking":[32],"PD-1,":[33],"sought":[34],"to":[35,148,197,265,323],"further":[36,337],"evaluate":[37],"the":[38,43],"safety":[39],"and":[40,54,82,122,150,166,224,295,315],"activity":[41,312],"10":[44,95,308],"mg/kg":[45,309],"dose.":[46,289],"Other":[47],"objectives":[48],"included":[49],"evaluation":[50],"pharmacokinetics":[52],"(PK)":[53],"immunological":[55,334],"effects.":[56],"Methods:":[57],"Patients":[58],"(pts)":[59],"with":[60,109,125,175,321,332],"treatment":[61],"refractory":[62],"metastatic":[63],"non-small":[64],"cell":[65,70,228],"lung":[66],"cancer":[67,74,80],"(NSCLC),":[68],"renal":[69],"carcinoma":[71],"(RCC),":[72],"colon":[73],"(CC),":[75],"melanoma":[76],"(MEL),":[77],"or":[78,112,330],"prostate":[79],"(CRPC),":[81],"no":[83,254],"history":[84],"autoimmune":[86],"disease":[87,111],"received":[88,201],"single":[90,288],"infusion":[91],"MDX-1106":[93,118,155,205,238,306,322],"at":[94,101,119,282,307],"mg/kg.":[96],"Disease":[97],"status":[98],"was":[99,239,243,253],"evaluated":[100],"week":[102],"(wk)":[103],"8":[104,138],"by":[105],"RECIST":[106],"criteria.":[107],"Pts":[108],"stable":[110],"lesional":[113],"responses":[114],"could":[115],"receive":[116],"additional":[117],"wks":[120],"12":[121],"16.":[123],"Those":[124],"PR/CR":[126],"were":[127,144,152,191],"observed":[128,248],"without":[129,209,317],"retreatment.":[130],"Results:":[131],"21":[132],"pts":[133,168],"(5":[134],"CC,":[135],"2":[136,167,194],"NSCLC,":[137],"MEL,":[139],"5":[140],"HRPC,":[141],"1":[142],"RCC)":[143],"treated":[145],"from":[146],"10/07":[147],"present,":[149],"6":[151],"retreated.":[153],"No":[154],"related":[156],"SAEs":[157],"occurred.":[158],"One":[159,173],"pt":[160,174],"developed":[161],"arthritic":[162],"symptoms":[163],"requiring":[164],"treatment,":[165],"had":[169,177],"asymptomatic":[170],"TSH":[171],"elevation.":[172],"RCC":[176,314],"PR":[179],"after":[180],"3":[181,284],"doses,":[182],"lasting":[183],"5+":[184],"months":[185],"(mo).":[186],"Lesional":[187],"regressions":[188],"(\u201cmixed":[189],"response\u201d)":[190],"seen":[192],"MEL":[195,216,316],"pts;":[196],"date,":[198],"one":[199],"has":[200],"7":[202],"doses":[203],"over":[206],"15":[207],"mo":[208,285],"serious":[210,318],"toxicity.":[211,319],"Biopsy":[212],"regressing":[215],"lymph":[217],"node":[218],"metastasis":[219],"showed":[220],"moderately":[222],"increased":[223],"selective":[225],"CD8+":[226],"infiltrate":[229],"post":[230],"treatment.":[231],"The":[232],"median":[233],"serum":[234],"t":[235],"1/2":[236],"20.6":[240],"days,":[241],"which":[242],"roughly":[244],"50%":[245],"longer":[246],"than":[247],"for":[249,281],"lower":[250],"doses.":[251],"There":[252],"evidence":[255],"immunogenicity":[257],"based":[258],"HAHA":[260],"development.":[261],"Interestingly,":[262],"contrast":[264],"PK":[266],"results,":[267],"flow":[268],"cytometric":[269],"analysis":[270],"demonstrated":[271,310],"sustained":[272],"occupancy":[273],"60\u201380%":[275],"PD-1":[276],"molecules":[277],"cells":[280],"least":[283],"following":[286],"Analyses":[290],"circulating":[292],"lymphocyte":[293],"subsets":[294],"tumor":[296],"B7-H1":[297],"expression":[298],"are":[299],"progress.":[301],"Conclusions:":[302],"Intermittent":[303],"dosing":[304],"clinical":[311],"against":[313],"Therapy":[320],"enhance":[324],"endogenous":[325],"immunity,":[327],"either":[328],"alone":[329],"combined":[331],"other":[333],"therapies,":[335],"warrants":[336],"study.":[338],"[Table:":[339],"see":[340],"text]":[341]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}